BeOne Medicines
ONC
#530
Rank
โ‚น4.258 T
Marketcap
โ‚น37,284
Share price
-0.97%
Change (1 day)
19.10%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): โ‚น774.46

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is โ‚น763.96. In 2025 the company made an earnings per share (EPS) of โ‚น254.65 an increase over its 2024 EPS that were of -โ‚น582.07.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น774.46204.12%
2025โ‚น254.65-143.75%
2024-โ‚น582.07
2022-โ‚น1,81928.21%
2021-โ‚น1,419-19.96%
2020-โ‚น1,77320.81%
2019-โ‚น1,46731.52%
2018-โ‚น1,116417.57%
2017-โ‚น215.55-37.16%
2016-โ‚น343.04158.95%
2015-โ‚น132.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น17.72-102.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น88.62-111.60%๐Ÿ‡บ๐Ÿ‡ธ USA